Trial intelligence / Profile preview

Inhaled vs Intravenous Milrinone in Cardiac Surgery

NCT04484675Phase 4Recruiting

Sponsor
Zagazig University
Start
May 2023
Primary completion
May 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of milrinone in pulmonary hypertension (PH), sponsored by Zagazig University. Started May 2023; status: recruiting.

02

Drugs

milrinone
03

Conditions

pulmonary hypertension (PH)

Beyond the preview

Go deeper on NCT04484675.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04484675.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call